Cystic fibrosis drug Trikafta helps most but not all with the deadly genetic disease
Автор: The Boston Globe
Загружено: 17 янв. 2024 г.
Просмотров: 4 705 просмотров
The cystic fibrosis drug Trikafta helps roughly 90 percent of people who have the deadly genetic disease. The drug enables patients to live a healthy life, start families, and think of a future. But for those left in the 10 percent, for whom Trikafta does not work, the daily struggles of living with a chronic, terminal illness continue. “Waiting for Hope, Fighting for Tomorrow” explores the lives of people at opposite ends of the spectrum: those who are benefiting from the drug, including young children who will escape much of the damage that CF causes, and those still waiting for their “miracle drug.”
Full story: https://bit.ly/45Vk1Ob
Доступные форматы для скачивания:
Скачать видео mp4
-
Информация по загрузке:
